Navigation Links
BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Date:6/25/2008

Pioneering firm marks milestone with initiatives aimed at knowledge

transfer, including landmark medical research collaboration between

Massachusetts and the Italian government in Lombardia

NEWTON, Mass., June 25 /PRNewswire/ -- BBK Worldwide, an innovator and leader in global patient recruitment for clinical trials, marks its 25th anniversary this year with a variety of initiatives to make its quarter-century of expertise more accessible to and beneficial for the life-sciences industry.

These efforts include a recent groundbreaking knowledge and technology transfer agreement between the Commonwealth of Massachusetts and the Lombardia region of Italy, and follow the recent release of BBK's comprehensive industry guidebook, Reinventing Patient Recruitment: Revolutionary Ideas for Clinical Trial Success, authored by the firm's co-founders, Bonnie A. Brescia, president, and Joan F. Bachenheimer, CEO and director of creative strategies.

"Just as business incubators accelerate the successful development of entrepreneurial companies through an array of support services, our aim has always been -- and continues to be -- to accelerate the patient enrollment process, helping sponsors conduct appropriate research with as many patients as possible," Brescia said.

"Since BBK opened its doors in July 1983, we've amassed a considerable body of knowledge regarding successful patient enrollment in clinical trials," Bachenheimer added. "We believe that transfer of this knowledge can contribute to enhancing the drug development process and reducing cycle time, which ultimately gets new medications to doctors and patients as expeditiously as possible."

BBK's current efforts include participation in the Clinical Research Consortium of Massachusetts (CRCM), a group of four organizations selected by the Massachusetts Office of International Trade and Investment to help Italy's Lombardia region attract more clinical studies and
'/>"/>

SOURCE BBK Worldwide
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
2. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
7. Getty Images Celebrates Conclusion of Change Me Imagery Forum
8. Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years
9. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
10. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
11. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Moms are ready to live the ... and their kids, according to the results of the ... Go Mobile for Moms, the latest installment in BabyCenter,s ... 1 pregnancy and parenting web and mobile destination worldwide, ... moms surveyed say they can,t think of a reason ...
(Date:10/22/2014)... , Oct. 22, 2014  Paper Pak ... has developed APLS ® Body Guard Bio, ... the spread of bacteria and virus while protecting ... Body Guard Bio features a rugged, external nylon ... that create a leak-proof inner chamber that contains ...
(Date:10/22/2014)... , Oct. 22, 2014 AVACEN Medical ... device received 510 (k) OTC clearance by the U.S. ... 100 to be marketed over the Internet for: ... muscle spasms; and minor strains and sprains . ... The AVACEN 100 (MSRP $2495) is a sophisticated medical ...
Breaking Medicine Technology:BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2
... PARSIPPANY, N.J. , Jan. 14 As ... market, the company has announced the addition of three Vice ... these positions bring a deep knowledge of the spine and ... distribution networks in their respective areas.   , Randy ...
... , HORSHAM, Pa. , ... 3 clinical study comparing the efficacy and safety of STELARA™ ... severe plaque psoriasis appear today in The New England ... clinical response with both doses of STELARA than with etanercept ...
Cached Medicine Technology:Custom Spine Announces the Expansion of its Sales Management Team 2STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 2STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 3STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 4STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 5STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 6STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 7STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 8STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine 9
(Date:10/22/2014)... October 22, 2014 Although there are only 24 ... for many people who have trouble finding time within their busy ... exercise for long periods of time to get in shape. Here ... while on the go. , Change Up Your Commute , ... work to add some exercise into your daily routine. If you ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter , ... add weight and length may be showing a genetic propensity ... adults, certain genes have been linked to increased body fat, ... fat and lean muscle, the researchers said. At 1 ... By ages 2 and 3, however, these genes were linked ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, ... vitro fertilization (IVF) -- the incubation of embryos in a ... inside the vagina, new research suggests. Scientists from the ... INVOcell, might sharply cut costs for pricey IVF procedures among ... to those who don,t live near big-city assisted reproduction centers, ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market ... of facts, figures and forecasts on the global medical ... forecast categories the Worldwide Medical Market Forecasts to ... views on the worldwide medical market to reveal key ... you data for 2010-2019, covering each country market individually, ...
(Date:10/20/2014)... ASCNYC (ascnyc.org) is a New ... Yorkers living with HIV/AIDS and other chronic conditions ... and self-sufficiency. Each year, ASCNYC spotlights selected “Positive ... their tireless efforts. , Savills Studley ... been selected as this year’s honoree for sharing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3
... 13 - Global innovation firm frog design today ... team with several new appointments. The new hires ... and building on its strong growth in multiple ... and brand strategy. Previously Creative Director for Nike,s ...
... 13 Genomic Health, Inc. (Nasdaq: GHDX ... Operating and Financial Officer, will present at the Eighth ... Tuesday, May 19, 2009 at 11:00 a.m. PT.To access ... visit the Investor Relations section of Genomic Health,s website ...
... 13 Celator Pharmaceuticals today announced that Scott Jackson, ... 2009 BIO International Convention in Atlanta. Mr. Jackson ... the company,s progress with two ongoing Phase 2 clinical ... (AML) patients and first-relapse AML patients. The presentation ...
... Fla., May 13 Ever since she was 6 years ... years of hard work and education she has her own ... their parents every day who want better health and more ... her new book, "Common Sense Pediatrics" ( published by ...
... Intelligent Charge Capture Emerges as Preferred Technology ... MedAptus(R), market leader for charge capture technologies, ... Physicians (UMP), a premier multi-specialty physician ... for charge capture automation.Founded in 1997 and ...
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... officer, is scheduled to present a company overview at the ... Wednesday, May 20th at 2:00 p.m. PT.To access the live ... www.rigel.com . Please connect to Rigel,s website several minutes ...
Cached Medicine News:Health News:frog design Strengthens Creative Leadership With New Appointments 2Health News:Celator(R) Pharmaceuticals to Present at 2009 BIO International Convention 2Health News:'Common Sense Pediatrics': Combining Alternative and Traditional Medicine in Everyday Practice 2Health News:University of Minnesota Physicians Chooses MedAptus Following Comprehensive Vendor Review 2Health News:University of Minnesota Physicians Chooses MedAptus Following Comprehensive Vendor Review 3
... provides optimized balance of pulse strength, pulse ... cleaning in the O.R. Unlike disposable plastic ... forged in die-cast metal and powered by ... The result is unparalleled performance in cleaning, ...
... 6000 lets you manually ... precise positioning. The superior ... immediate and exact positioning ... making it especially effective ...
... SP Surgical Table combines innovation and design ... up to 1,000 lbs. You can safely ... normal and reverse orientation and have virtually ... patients.,The Amsco 3085 SP Table offers the ...
... The hands play an important part ... traumatic impairments and rheumatic changes can cause ... developing of the finger-joint prostheses was to ... reproduce the natural function as nearly possible.,The ...
Medicine Products: